348 related articles for article (PubMed ID: 15791440)
1. Quantitation of dopamine transporter blockade by methylphenidate: first in vivo investigation using [123I]FP-CIT and a dedicated small animal SPECT.
Nikolaus S; Wirrwar A; Antke C; Arkian S; Schramm N; Müller HW; Larisch R
Eur J Nucl Med Mol Imaging; 2005 Mar; 32(3):308-13. PubMed ID: 15791440
[TBL] [Abstract][Full Text] [Related]
2. In-vivo quantification of dose-dependent dopamine transporter blockade in the rat striatum with small animal SPECT.
Nikolaus S; Antke C; Beu M; Kley K; Larisch R; Wirrwar A; Müller HW
Nucl Med Commun; 2007 Mar; 28(3):207-13. PubMed ID: 17264780
[TBL] [Abstract][Full Text] [Related]
3. Imaging of dopamine transporters with iodine-123-FP-CIT SPECT in healthy controls and patients with Parkinson's disease.
Booij J; Habraken JB; Bergmans P; Tissingh G; Winogrodzka A; Wolters EC; Janssen AG; Stoof JC; van Royen EA
J Nucl Med; 1998 Nov; 39(11):1879-84. PubMed ID: 9829575
[TBL] [Abstract][Full Text] [Related]
4. Pretreatment with haloperidol reduces (123)I-FP-CIT binding to the dopamine transporter in the rat striatum: an in vivo imaging study with a dedicated small-animal SPECT camera.
Nikolaus S; Antke C; Kley K; Beu M; Wirrwar A; Müller HW
J Nucl Med; 2009 Jul; 50(7):1147-52. PubMed ID: 19525450
[TBL] [Abstract][Full Text] [Related]
5. Iodine-123-beta-CIT and iodine-123-FPCIT SPECT measurement of dopamine transporters in healthy subjects and Parkinson's patients.
Seibyl JP; Marek K; Sheff K; Zoghbi S; Baldwin RM; Charney DS; van Dyck CH; Innis RB
J Nucl Med; 1998 Sep; 39(9):1500-8. PubMed ID: 9744331
[TBL] [Abstract][Full Text] [Related]
6. 123I-FP-CIT SPECT imaging of dopamine transporters in patients with cerebrovascular disease and clinical diagnosis of vascular parkinsonism.
Lorberboym M; Djaldetti R; Melamed E; Sadeh M; Lampl Y
J Nucl Med; 2004 Oct; 45(10):1688-93. PubMed ID: 15471834
[TBL] [Abstract][Full Text] [Related]
7. Measurement of [123I]FP-CIT binding to the dopamine transporter (DAT) in healthy mouse striatum using dedicated small animal SPECT imaging: feasibility, optimization and validation.
Greco A; Zannetti A; Pappatà S; Albanese S; Coda AR; Ragucci M; Nardelli A; Brunetti A; Cuocolo A; Salvatore M
Q J Nucl Med Mol Imaging; 2018 Mar; 62(1):112-117. PubMed ID: 26329495
[TBL] [Abstract][Full Text] [Related]
8. Iodine-123-N-omega-fluoropropyl-2beta-carbomethoxy-3beta-(4-iod ophenyl)tropane SPECT in healthy controls and early-stage, drug-naive Parkinson's disease.
Tissingh G; Booij J; Bergmans P; Winogrodzka A; Janssen AG; van Royen EA; Stoof JC; Wolters EC
J Nucl Med; 1998 Jul; 39(7):1143-8. PubMed ID: 9669384
[TBL] [Abstract][Full Text] [Related]
9. [123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease.
Booij J; Tissingh G; Boer GJ; Speelman JD; Stoof JC; Janssen AG; Wolters EC; van Royen EA
J Neurol Neurosurg Psychiatry; 1997 Feb; 62(2):133-40. PubMed ID: 9048712
[TBL] [Abstract][Full Text] [Related]
10. [123I]FP-CIT binds to the dopamine transporter as assessed by biodistribution studies in rats and SPECT studies in MPTP-lesioned monkeys.
Booij J; Andringa G; Rijks LJ; Vermeulen RJ; De Bruin K; Boer GJ; Janssen AG; Van Royen EA
Synapse; 1997 Nov; 27(3):183-90. PubMed ID: 9329154
[TBL] [Abstract][Full Text] [Related]
11. [Phase 1 clinical study of 123I-FP-CIT, a new radioligand for evaluating dopamine transporter with SPECT (I): Biodistribution and absorbed dose].
Takano K; Matsumura K; Watanabe Y; Yamada T; Kubo H; Naitou Y; Narita Y; Kuzuhara S; Takeda K
Kaku Igaku; 1999 Sep; 36(7):735-44. PubMed ID: 10547983
[TBL] [Abstract][Full Text] [Related]
12. Clinical testing of an optimized software solution for an automated, observer-independent evaluation of dopamine transporter SPECT studies.
Koch W; Radau PE; Hamann C; Tatsch K
J Nucl Med; 2005 Jul; 46(7):1109-18. PubMed ID: 16000279
[TBL] [Abstract][Full Text] [Related]
13. Human biodistribution and dosimetry of [123I]FP-CIT: a potent radioligand for imaging of dopamine transporters.
Booij J; Busemann Sokole E; Stabin MG; Janssen AG; de Bruin K; van Royen EA
Eur J Nucl Med; 1998 Jan; 25(1):24-30. PubMed ID: 9396871
[TBL] [Abstract][Full Text] [Related]
14. Imaging of striatal dopamine transporters in rat brain with single pinhole SPECT and co-aligned MRI is highly reproducible.
Booij J; de Bruin K; de Win MM; Lavini C; den Heeten GJ; Habraken JB
Nucl Med Biol; 2003 Aug; 30(6):643-9. PubMed ID: 12900290
[TBL] [Abstract][Full Text] [Related]
15. [123I]Iodobenzamide binding to the rat dopamine D2 receptor in competition with haloperidol and endogenous dopamine--an in vivo imaging study with a dedicated small animal SPECT.
Nikolaus S; Larisch R; Wirrwar A; Jamdjeu-Nouné M; Antke C; Beu M; Schramm N; Müller HW
Eur J Nucl Med Mol Imaging; 2005 Nov; 32(11):1305-10. PubMed ID: 16003562
[TBL] [Abstract][Full Text] [Related]
16. Serotonin transporters in dopamine transporter imaging: a head-to-head comparison of dopamine transporter SPECT radioligands 123I-FP-CIT and 123I-PE2I.
Ziebell M; Holm-Hansen S; Thomsen G; Wagner A; Jensen P; Pinborg LH; Knudsen GM
J Nucl Med; 2010 Dec; 51(12):1885-91. PubMed ID: 21078806
[TBL] [Abstract][Full Text] [Related]
17. [TierSPECT: performance of a dedicated small-animal-SPECT camera and first in vivo measurements].
Wirrwar AK; Nikolaus S; Schramm NU; Arkian S; Cohnen M; Müller HW
Z Med Phys; 2005; 15(1):14-22. PubMed ID: 15830780
[TBL] [Abstract][Full Text] [Related]
18. [Striatal dopamine transporter levels in patients with REM sleep behavior disorder: assessment with 123I-FP-CIT SPECT].
Mossa EP; Niccoli Asabella A; Iuele F; Stabile Ianora AA; Giganti M; Rubini G
Recenti Prog Med; 2012 Nov; 103(11):500-4. PubMed ID: 23096739
[TBL] [Abstract][Full Text] [Related]
19. Dopamine transporter SPECT using fast kinetic ligands: 123I-FP-beta-CIT versus 99mTc-TRODAT-1.
Van Laere K; De Ceuninck L; Dom R; Van den Eynden J; Vanbilloen H; Cleynhens J; Dupont P; Bormans G; Verbruggen A; Mortelmans L
Eur J Nucl Med Mol Imaging; 2004 Aug; 31(8):1119-27. PubMed ID: 15064872
[TBL] [Abstract][Full Text] [Related]
20. Comparative nigrostriatal dopaminergic imaging with iodine-123-beta CIT-FP/SPECT and fluorine-18-FDOPA/PET.
Ishikawa T; Dhawan V; Kazumata K; Chaly T; Mandel F; Neumeyer J; Margouleff C; Babchyck B; Zanzi I; Eidelberg D
J Nucl Med; 1996 Nov; 37(11):1760-5. PubMed ID: 8917170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
